Covid-19 Drug Control Based on BPOM Informatorium with ABC Method at the Pharmacies of Bandung City
Abstract
According to statistical data from JHU CSSE COVID-19 in June 2021, there was an increase in positive cases of Coronavirus and began to decline at the end of August 2021. The planning that has been made must be corrected using the ABC method because a type of drug can consume a large budget if it is used a lot and is expensive. The purpose of this ABC value analysis is to identify the types of drugs from the scale of use that require the most costs. This type of non-experimental research uses descriptive methods through retrospective quantitative data collection using previous data, namely June – August 2021. Based on the scale of the use of Covid-19 drugs which are included in group A with the highest number of uses, it is necessary to ensure the availability of sufficient stock for avoid stock shortages that can hamper patient care in hospitals and can cause losses to hospitals. Drugs that are included in group B are adequately controlled by using warehouse stock cards and stock cards in the compounding and retail sales rooms. Drug group C needs to be controlled so that the number of drugs is not too excessive to avoid losses due to expired or damaged drugs. A review of the ABC analysis can be carried out annually along with the determination of the use of a standard drug list and the preparation of an annual budget plan.
Keywords
Full Text:
PDFReferences
Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU, Journal of Pharmaceutical Sciences, 28(2), 799–805. https://doi.org/10.1007/s40199-020- 00358-5
Bogadenta, A. (2012). Pharmacy Management Management (Edisi I.D-).
BPOM RI. (2020a). Information on Covid-19 Drugs in Indonesia (Edisi 1).
BPOM RI. (2020b). Information on Covid-19 Drugs in Indonesia, Edition 2, Food and Drug Supervisory Agency of the Republic of Indonesia (Edisi 2).
BPOM RI. (2021). 2019 (COVID-19). Edisi 3.
Carr, A. C., & Rowe, S. (2020). The emerging role of vitamin c in the prevention and treatment of covid-19. In Nutrients (Vol. 12, Issue 11, pp. 1–8). MDPI AG. https://doi.org/10.3390/nu12113286
Dabbous, H. M., Abd-Elsalam, S., El-Sayed, M. H., Sherief, A. F., Ebeid, F. F. S., El Ghafar, M. S. A., Soliman, S., Elbahnasawy, M., Badawi, R., & Tageldin, M. A. (2021). Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Archives of Virology, 166(3). https://doi.org/10.1007/s00705-021-04956- 9
De Flora, S., Balansky, R., & La Maestra, S. (2020). Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB Journal, 34(10), 13185–13193. https://doi.org/10.1096/fj.202001807
Elbeddini, A., Tayefehchamani, Y., & Yang, L. (2020). Strategies to conserve salbutamol pressurized metered- dose inhaler stock levels amid COVID-19 drug shortage. Drugs and Therapy Perspectives, 36(10), 451– 454. https://doi.org/10.1007/s40267-020-00759-1
Farizi, S. Al, & Harmawan, B. N. (2020). Data Transparency And Information Sharing: Coronavirus Prevention Problems In Indonesia. Jurnal Administrasi Kesehatan Indonesia, 8(2), 35. https://doi.org/10.20473/jaki.v8i2.2020.35-50
Hua, J., & Shaw, R. (2020). Corona virus (Covid-19) “infodemic” and emerging issues through a data lens: The case of china. International Journal of Environmental Research and Public Health, 17(7). https://doi.org/10.3390/IJERPH17072309
Indonesia, K. K. R. (2017). Regulation of the Minister of Health of the Republic of Indonesia Number 9 of 2017 concerning Pharmacies. Regulation of the Minister of Health of the Republic of Indonesia Number 9 of 2017 concerning Pharmacies,1–36.
JHU CSSE. (n.d.). COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.
Karampela, I., & Dalamaga, M. (2020). Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? Archives of Medical Research, 51(7), 741–742. https://doi.org/10.1016/j.arcmed.2020.06.004
Kemenkes RI. (2021). Decree of the Minister of Health of the Republic of Indonesia Number HK. 01.07/MENKES/4826/2021 Concerning the Highest Retail Prices for Medicines during the COVID-19 Pandemic. 2019, 2019–2022.
Pani, A., Lauriola, M., Romandini, A., & Scaglione, F. (2020). Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. In International Journal of Antimicrobial Agents (Vol. 56, Issue 2). Elsevier B.V. https://doi.org/10.1016/j.ijantimicag.2020.106053
Prisanti, W. and, A. K. N. S. M. P. and, S. D. S. K. M. P. (2019). Analysis of Drug Planning and Procurement Using the ABC Analysis Method at the RSIA Aisyiyah Klaten Pharmacy Installation.
World Health Organization. (2020). Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the- coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
World Health Organization. (2022). Tracking SARS-CoV-2 Variants (https://www. who. int/en/activities/tracking-SARS-CoV-2-variants/).
DOI: https://doi.org/10.46336/ijbesd.v5i1.587
Refbacks
- There are currently no refbacks.
Add comment
Copyright (c) 2024 International Journal of Business, Economics, and Social Development
This work is licensed under a Creative Commons Attribution 4.0 International License.
Published By:
IJBESD: Jalan Riung Ampuh No. 3, Riung Bandung, Kota Bandung 40295, Jawa Barat, Indonesia
IJBESD Indexed By:
This work is licensed under a Creative Commons Attribution 4.0 International License.